Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Cerundolo

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptaseA K Sewell, D A Price, H Teisserenc, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I moleculesM Colonna, J Samaridis, M Cella, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responsesP André, M Groettrup, P Klenerman, et al.
Clinical and Experimental Immunology|February 15, 2016
Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infectionA Kamaladasa, N Wickramasinghe, T N Adikari, et al.
The Journal of Experimental Medicine|September 28, 1999
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytesD E Speiser, M J Pittet, D Valmori, et al.
The Journal of Experimental Medicine|September 8, 1999
An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesionsA Anichini, A Molla, R Mortarini, et al.
The Journal of Experimental Medicine|September 8, 1999
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individualsM J Pittet, D Valmori, P R Dunbar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic proteinU Gileadi, H T Moins-Teisserenc, I Correa, et al.
The Journal of Experimental Medicine|November 6, 1998
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytesP Romero, P R Dunbar, D Valmori, et al.
The Journal of Experimental Medicine|July 1, 1992
Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognitionR S van Binnendijk, C A van Baalen, M C Poelen, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|June 8, 1999
IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptaseA K Sewell, D A Price, H Teisserenc, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 8, 1998
Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I moleculesM Colonna, J Samaridis, M Cella, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 1998
An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responsesP André, M Groettrup, P Klenerman, et al.
Clinical and Experimental Immunology|February 15, 2016
Expansion of highly activated invariant natural killer T cells with altered phenotype in acute dengue infectionA Kamaladasa, N Wickramasinghe, T N Adikari, et al.
The Journal of Experimental Medicine|September 28, 1999
In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytesD E Speiser, M J Pittet, D Valmori, et al.
The Journal of Experimental Medicine|September 8, 1999
An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesionsA Anichini, A Molla, R Mortarini, et al.
The Journal of Experimental Medicine|September 8, 1999
High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individualsM J Pittet, D Valmori, P R Dunbar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 1999
Generation of an immunodominant CTL epitope is affected by proteasome subunit composition and stability of the antigenic proteinU Gileadi, H T Moins-Teisserenc, I Correa, et al.
The Journal of Experimental Medicine|November 6, 1998
Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytesP Romero, P R Dunbar, D Valmori, et al.
The Journal of Experimental Medicine|July 1, 1992
Measles virus transmembrane fusion protein synthesized de novo or presented in immunostimulating complexes is endogenously processed for HLA class I- and class II-restricted cytotoxic T cell recognitionR S van Binnendijk, C A van Baalen, M C Poelen, et al.
Pageof 10